Why the study?
Extracardiac Fontan lacks growth potential and may cause late flow stagnation compared to lateral tunnel Fontan, prompting investigation into cross-sectional area changes and their impact on liver fibrosis.
Does extracardiac Fontan compared to lateral tunnel Fontan affect pathway cross-sectional area and liver fibrosis progression?
Does extracardiac Fontan compared to lateral tunnel Fontan affect pathway cross-sectional area and liver fibrosis progression?
Following extracardiac Fontan, the pathway's indexed cross-sectional area decreases over time, and narrowing (<156 mm2/m2) is a risk factor for liver fibrosis progression.
Answers are grounded in this paper and cite their sources.
Indexed cross-sectional area <156 mm²/m² after extracardiac Fontan may warrant liver fibrosis screening; leaves open whether lateral tunnel mitigates this risk.
Background/Objectives: A known disadvantage of extracardiac Fontan is the absence of growth potential and potential late flow stagnation compared to lateral tunnel Fontan. This study investigates the differences in changes in the cross-sectional area and impact on liver fibrosis. Methods: The anteroposterior and lateral diameters of the Fontan pathways were measured using angiograms. Cross-sectional area and the indexed cross-sectional area were calculated, and their relation to Fibrosis-4 index was analyzed. Results: A total of 334 angiograms of 224 patients (212 extracardiac and 12 lateral tunnel Fontan) were evaluated. The median age at Fontan was 2.2 (Interquartile Range: 1.8–2.9) years. The median period from Fontan to angiogram was 3.3 (0.04–10.8) years. Cross-sectional areas remained unchanged in extracardiac Fontan patients and increased in lateral tunnel Fontan patients. The indexed cross-sectional areas in extracardiac Fontan patients decreased over time. The smallest indexed-cross-sectional areas were 200 mm2/m2 in extracardiac Fontan patients at 10 years postoperatively, whereas indexed cross-sectional areas in lateral tunnel Fontan patients were larger and more variable. Fibrosis-4 index increased time-dependently in both groups. Indexed cross-sectional area at the smallest level <156 mm2/m2 was identified as a risk factor for liver fibrosis. Conclusions: The Fontan pathway expanded in patients after lateral tunnel Fontan, whereas indexed cross-sectional area decreased over time after extracardiac Fontan. Importantly, in patients after extracardiac Fontan, narrowing of the Fontan pathway might be one of the risk factors for progression of liver fibrosis.
No takes yet. Share an insight, caveat, or question.
Piber et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: